Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$71.60 /

+2.48 (+3.59%)

11:05
10/19/20
10/19
11:05
10/19/20
11:05

Sage changes to '217 study should improve odds of success, says RBC Capital

RBC Capital analyst Brian Abrahams noted that the clinicaltrials.gov listing for Sage Therapeutics' Phase 3 major depressive disorder study of lead drug '217 was updated to indicate "meaningful expansion" of the number of patients enrolled to 370, up from 240. After speaking with the company about it, Abrahams said his sense is that the company is "aiming to maximize the robustness of data across potential subgroups and subanalyses." While the changes were not specifically made to improve powering on the primary endpoint, he thinks that a larger sample size should help further improve the powering and probability of success, added Abrahams, who keeps an Outperform rating on Sage shares with a $75 price target.

SAGE Sage Therapeutics
$71.60 /

+2.48 (+3.59%)

10/16/20 BMO Capital
Sage Therapeutics price target raised to $79 from $65 at BMO Capital
09/11/20 Wedbush
Sage Therapeutics upgraded to Outperform from Neutral at Wedbush
09/11/20 Citi
Sage Therapeutics price target raised to $67 from $54 at Citi
09/11/20 Wedbush
Sage Therapeutics upgraded to Outperform from Neutral at Wedbush

TODAY'S FREE FLY STORIES

Hot Stocks
Accenture, Microsoft collaborate with CNH Industrial on connected vehicles » 05:37
11/30/20
11/30
05:37
11/30/20
05:37
ACN

Accenture

$251.99 /

+2.63 (+1.05%)

, MSFT

Microsoft

$215.14 /

+1.18 (+0.55%)

, CNHI

CNH Industrial

$11.03 /

-0.21 (-1.87%)

Accenture (ACN) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$251.99 /

+2.63 (+1.05%)

MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

CNHI CNH Industrial
$11.03 /

-0.21 (-1.87%)

ACN Accenture
$251.99 /

+2.63 (+1.05%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Accenture initiated with a Buy at Goldman Sachs
09/28/20 Barclays
Accenture price target lowered to $245 from $260 at Barclays
09/25/20 JPMorgan
Accenture price target lowered to $252 from $256 at JPMorgan
MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
11/27/20 DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/25/20 Goldman Sachs
Goldman says Salesforce potential deal for Slack 'may have strategic merit'
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
CNHI CNH Industrial
$11.03 /

-0.21 (-1.87%)

11/11/20 BofA
CNH Industrial upgraded to Buy from Neutral at BofA
11/11/20 BofA
CNH Industrial upgraded to Buy from Neutral at BofA
11/06/20 Deutsche Bank
CNH Industrial price target raised to $12 from $9 at Deutsche Bank
09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
ACN Accenture
$251.99 /

+2.63 (+1.05%)

MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

CNHI CNH Industrial
$11.03 /

-0.21 (-1.87%)

ACN Accenture
$251.99 /

+2.63 (+1.05%)

MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

ACN Accenture
$251.99 /

+2.63 (+1.05%)

MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

CNHI CNH Industrial
$11.03 /

-0.21 (-1.87%)

ACN Accenture
$251.99 /

+2.63 (+1.05%)

MSFT Microsoft
$215.14 /

+1.18 (+0.55%)

Downgrade
Magnolia Oil & Gas downgraded to Neutral from Buy at MKM Partners » 05:36
11/30/20
11/30
05:36
11/30/20
05:36
MGY

Magnolia Oil & Gas

$7.00 /

+0.1 (+1.45%)

MKM Partners analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MGY Magnolia Oil & Gas
$7.00 /

+0.1 (+1.45%)

MGY Magnolia Oil & Gas
$7.00 /

+0.1 (+1.45%)

11/18/20 Piper Sandler
Magnolia Oil & Gas price target raised to $6 from $5 at Piper Sandler
11/06/20 Northland
Magnolia Oil & Gas upgraded to Outperform from Market Perform at Northland
10/22/20 Piper Sandler
Magnolia Oil & Gas price target lowered to $5 from $8 at Piper Sandler
09/11/20 Susquehanna
Valuations on E&P group relatively full, says Susquehanna
MGY Magnolia Oil & Gas
$7.00 /

+0.1 (+1.45%)

Downgrade
Centennial Resource Development downgraded to Neutral from Buy at MKM Partners » 05:36
11/30/20
11/30
05:36
11/30/20
05:36
CDEV

Centennial Resource Development

$1.27 /

+0.005 (+0.40%)

MKM Partners analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDEV Centennial Resource Development
$1.27 /

+0.005 (+0.40%)

10/22/20 Piper Sandler
Centennial Resource upgraded to Neutral from Underweight at Piper Sandler
09/14/20 Wells Fargo
Centennial Resource Development downgraded to Underweight from Equal Weight at Wells Fargo
05/06/20 TD Securities
Centennial Resource downgraded to Reduce with 80c target at TD Securities
05/05/20 TD Securities
Centennial Resource Development downgraded to Reduce from Hold at TD Securities
CDEV Centennial Resource Development
$1.27 /

+0.005 (+0.40%)

Downgrade
PPL Corp. downgraded to Neutral from Buy at BofA » 05:33
11/30/20
11/30
05:33
11/30/20
05:33
PPL

PPL Corp.

$29.23 /

-0.17 (-0.58%)

BofA downgraded PPL Corp.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

08/19/20
Fly Intel: Top five analyst downgrades
08/19/20 Mizuho
PPL Corp. downgraded to Neutral from Buy at Mizuho
08/19/20 Mizuho
PPL Corp. downgraded to Neutral from Buy at Mizuho
08/11/20
Fly Intel: Top five analyst upgrades
PPL PPL Corp.
$29.23 /

-0.17 (-0.58%)

Initiation
Chegg initiated with a Buy at BofA » 05:33
11/30/20
11/30
05:33
11/30/20
05:33
CHGG

Chegg

$74.92 /

+2.37 (+3.27%)

BofA initiated coverage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$74.92 /

+2.37 (+3.27%)

CHGG Chegg
$74.92 /

+2.37 (+3.27%)

11/06/20
Fly Intel: Top five analyst initiations
11/06/20 Exane BNP Paribas
Chegg initiated with an Underperform at Exane BNP Paribas
10/27/20 Lake Street
Chegg price target raised to $85 from $79 at Lake Street
10/20/20 Morgan Stanley
Morgan Stanley sees more upside as likely for Chegg
CHGG Chegg
$74.92 /

+2.37 (+3.27%)

CHGG Chegg
$74.92 /

+2.37 (+3.27%)

CHGG Chegg
$74.92 /

+2.37 (+3.27%)

CHGG Chegg
$74.92 /

+2.37 (+3.27%)

Initiation
OncoCyte initiated with a Buy at BTIG » 05:31
11/30/20
11/30
05:31
11/30/20
05:31
OCX

OncoCyte

$1.78 /

+0.065 (+3.79%)

BTIG analyst Mark Massaro…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OCX OncoCyte
$1.78 /

+0.065 (+3.79%)

OCX OncoCyte
$1.78 /

+0.065 (+3.79%)

11/13/20 Piper Sandler
OncoCyte price target raised to $2 from $1.50 at Piper Sandler
11/09/20 KeyBanc
OncoCyte initiated with an Overweight at KeyBanc
07/01/20
Fly Intel: Top five analyst downgrades
06/30/20 Piper Sandler
OncoCyte downgraded to Neutral from Overweight at Piper Sandler
OCX OncoCyte
$1.78 /

+0.065 (+3.79%)

OCX OncoCyte
$1.78 /

+0.065 (+3.79%)

Hot Stocks
Masimo announces findings from PVi study published » 05:31
11/30/20
11/30
05:31
11/30/20
05:31
MASI

Masimo

$254.28 /

+8.41 (+3.42%)

Masimo announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MASI Masimo
$254.28 /

+8.41 (+3.42%)

MASI Masimo
$254.28 /

+8.41 (+3.42%)

11/02/20 Piper Sandler
Masimo acquisition brings 'solid opportunity,' says Piper Sandler
10/28/20 Piper Sandler
Masimo price target raised to $280 from $250 at Piper Sandler
10/06/20 Piper Sandler
Better than expected sensor utilization drove Masimo upside, says Piper Sandler
09/01/20 Baird
Masimo initiated with an Outperform at Baird
MASI Masimo
$254.28 /

+8.41 (+3.42%)

MASI Masimo
$254.28 /

+8.41 (+3.42%)

Hot Stocks
Amazon Web Services selected by Itau Unibanco as long-term cloud provider » 05:25
11/30/20
11/30
05:25
11/30/20
05:25
AMZN

Amazon.com

$3,198.14 /

+14.02 (+0.44%)

, ITUB

Itau Unibanco

$5.50 /

-0.04 (-0.72%)

Amazon Web Services, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

11/27/20 Truist
Amazon to claim 42c of every e-commerce dollar spent, says Truist
11/27/20 MKM Partners
Facebook, Google may also be interested in Slack, says MKM Partners
11/27/20 DA Davidson
Salesforce acquisition of Slack would 'make sense', says DA Davidson
11/23/20 Goldman Sachs
GoodRx price target lowered to $44 from $49 at Goldman Sachs
ITUB Itau Unibanco
$5.50 /

-0.04 (-0.72%)

06/15/20 Goldman Sachs
Itau Unibanco downgraded to Neutral from Buy at Goldman Sachs
04/06/20 Goldman Sachs
Itau Unibanco upgraded to Buy from Sell at Goldman Sachs
04/01/20 UBS
Itau Unibanco upgraded to Buy from Neutral at UBS
AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

AMZN Amazon.com
$3,198.14 /

+14.02 (+0.44%)

ITUB Itau Unibanco
$5.50 /

-0.04 (-0.72%)

Upgrade
Vertex upgraded to Outperform from Sector Perform at RBC Capital » 05:23
11/30/20
11/30
05:23
11/30/20
05:23
VRTX

Vertex Pharmaceuticals

$226.72 /

+8.62 (+3.95%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
Vertex Pharmaceuticals initiated with an Outperform at Bernstein
11/04/20 Piper Sandler
Crispr Therapeutics' CTX001 abstract shows longer durability, says Piper Sandler
11/02/20 Baird
Baird starts Editas Medicine with Underperform, $14 price target
VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

VRTX Vertex Pharmaceuticals
$226.72 /

+8.62 (+3.95%)

Downgrade
PTC Therapeutics downgraded to Underperform from Sector Perform at RBC Capital » 05:22
11/30/20
11/30
05:22
11/30/20
05:22
PTCT

PTC Therapeutics

$63.97 /

+0.46 (+0.72%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

10/30/20 Citi
Citi downgrades PTC Therapeutics to Neutral, sees shares being range-bound
10/30/20 Citi
PTC Therapeutics downgraded to Neutral from Buy at Citi
10/30/20 Cantor Fitzgerald
PTC Therapeutics price target lowered to $67 from $75 at Cantor Fitzgerald
10/28/20 UBS
PTC Therapeutics initiated with a Neutral at UBS
PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

PTCT PTC Therapeutics
$63.97 /

+0.46 (+0.72%)

Downgrade
Yunji downgraded to Underweight from Equal Weight at Morgan Stanley » 05:22
11/30/20
11/30
05:22
11/30/20
05:22
YJ

Yunji

$3.63 /

-1.26 (-25.77%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YJ Yunji
$3.63 /

-1.26 (-25.77%)

YJ Yunji
$3.63 /

-1.26 (-25.77%)

03/25/20 Credit Suisse
Yunji downgraded to Neutral from Outperform at Credit Suisse
02/04/20 Morgan Stanley
Morgan Stanley cuts Yunji to Equal Weight on competition and coronavirus
02/04/20 Morgan Stanley
Yunji downgraded to Equal Weight from Overweight at Morgan Stanley
YJ Yunji
$3.63 /

-1.26 (-25.77%)

Downgrade
Femsa downgraded to Market Perform from Outperform at Itau BBA » 05:21
11/30/20
11/30
05:21
11/30/20
05:21
FMX

Femsa

$74.29 /

-1.66 (-2.19%)

Itau BBA analyst Joaquin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMX Femsa
$74.29 /

-1.66 (-2.19%)

FMX Femsa
$74.29 /

-1.66 (-2.19%)

05/04/20 BofA
Femsa downgraded to Underperform from Neutral at BofA
01/07/20 Citi
Femsa upgraded to Buy from Neutral at Citi
FMX Femsa
$74.29 /

-1.66 (-2.19%)

Hot Stocks
Altice Europe shareholder Lucerne objects to Next Private acquisition offer » 05:20
11/30/20
11/30
05:20
11/30/20
05:20
ALLVF

Altice Europe

$0.00 /

+ (+0.00%)

Lucerne Capital, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLVF Altice Europe
$0.00 /

+ (+0.00%)

ALLVF Altice Europe
$0.00 /

+ (+0.00%)

10/28/20 Deutsche Bank
Altice Europe price target raised to EUR 9.75 from EUR 9 at Deutsche Bank
10/12/20 Barclays
Altice Europe upgraded to Equal Weight from Underweight at Barclays
09/14/20 HSBC
HSBC downgrades Altice Europe after 'not that generous' buyout offer
09/14/20 HSBC
Altice Europe downgraded to Hold from Buy at HSBC
Upgrade
Cia Paranaense upgraded to Neutral from Underperform at Credit Suisse » 05:20
11/30/20
11/30
05:20
11/30/20
05:20
ELPVY

Cia Paranaense

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Upgrade
Cemex upgraded to Outperform from Market Perform at BBVA » 05:19
11/30/20
11/30
05:19
11/30/20
05:19
CX

Cemex

$4.68 /

-0.02 (-0.43%)

BBVA analyst Francisco…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CX Cemex
$4.68 /

-0.02 (-0.43%)

CX Cemex
$4.68 /

-0.02 (-0.43%)

11/20/20 Santander
Cemex downgraded to Hold from Buy at Santander
11/17/20 Citi
Cemex initiated with a Buy at Citi
11/17/20 Citi
Cemex initiated with a Buy at Citi
09/29/20 UBS
Cemex initiated with a Buy at UBS
CX Cemex
$4.68 /

-0.02 (-0.43%)

Upgrade
Azul upgraded to Buy from Neutral at BTG Pactual » 05:19
11/30/20
11/30
05:19
11/30/20
05:19
AZUL

Azul

$20.73 /

+0.34 (+1.67%)

BTG Pactual analyst Lucas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZUL Azul
$20.73 /

+0.34 (+1.67%)

AZUL Azul
$20.73 /

+0.34 (+1.67%)

11/23/20 Raymond James
Azul price target raised to $23 from $16 at Raymond James
11/09/20 Seaport Global
Azul upgraded to Buy from Neutral at Seaport Global
11/09/20 Seaport Global
Azul upgraded to Buy from Neutral at Seaport Global
09/30/20 Goldman Sachs
Azul, Gol Linhas, Volaris upgraded to Buy at Goldman Sachs
AZUL Azul
$20.73 /

+0.34 (+1.67%)

Upgrade
U.S. Bancorp upgraded to Equal Weight from Underweight at Morgan Stanley » 05:17
11/30/20
11/30
05:17
11/30/20
05:17
USB

U.S. Bancorp

$44.17 /

-0.53 (-1.19%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

10/07/20 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
10/07/20 BofA
U.S. Bancorp upgraded to Neutral from Underperform at BofA
10/06/20 JPMorgan
U.S. Bancorp price target raised to $43.50 from $37.50 at JPMorgan
07/31/20 Wolfe Research
U.S. Bancorp initiated with an Outperform at Wolfe Research
USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

USB U.S. Bancorp
$44.17 /

-0.53 (-1.19%)

Upgrade
Synchrony upgraded to Overweight from Equal Weight at Morgan Stanley » 05:17
11/30/20
11/30
05:17
11/30/20
05:17
SYF

Synchrony

$30.98 /

-0.41 (-1.31%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYF Synchrony
$30.98 /

-0.41 (-1.31%)

SYF Synchrony
$30.98 /

-0.41 (-1.31%)

10/21/20 RBC Capital
Synchrony price target raised to $32 from $28 at RBC Capital
10/20/20 Stephens
Keeping Sam's Club a 'nice win' for Synchrony, says Stephens
10/09/20 JPMorgan
Synchrony price target raised to $30 from $24.50 at JPMorgan
10/05/20 Goldman Sachs
Synchrony price target raised to $34 from $30 at Goldman Sachs
SYF Synchrony
$30.98 /

-0.41 (-1.31%)

SYF Synchrony
$30.98 /

-0.41 (-1.31%)

SYF Synchrony
$30.98 /

-0.41 (-1.31%)

SYF Synchrony
$30.98 /

-0.41 (-1.31%)

Upgrade
BNY Mellon upgraded to Equal Weight from Underweight at Morgan Stanley » 05:17
11/30/20
11/30
05:17
11/30/20
05:17
BK

BNY Mellon

$39.92 /

-0.45 (-1.11%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BK BNY Mellon
$39.92 /

-0.45 (-1.11%)

BK BNY Mellon
$39.92 /

-0.45 (-1.11%)

11/20/20
Fly Intel: Top five analyst downgrades
11/20/20 BofA
BNY Mellon downgraded to Underperform from Neutral at BofA
11/20/20 BofA
BNY Mellon downgraded to Underperform from Neutral at BofA
11/18/20 Keefe Bruyette
BNY Mellon downgraded to Market Perform at Keefe Bruyette
BK BNY Mellon
$39.92 /

-0.45 (-1.11%)

BK BNY Mellon
$39.92 /

-0.45 (-1.11%)

BK BNY Mellon
$39.92 /

-0.45 (-1.11%)

Upgrade
Capital One upgraded to Overweight from Equal Weight at Morgan Stanley » 05:16
11/30/20
11/30
05:16
11/30/20
05:16
COF

Capital One

$87.77 /

-2.08 (-2.31%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COF Capital One
$87.77 /

-2.08 (-2.31%)

COF Capital One
$87.77 /

-2.08 (-2.31%)

11/18/20 Compass Point
Capital One price target raised to $102 from $78 at Compass Point
11/12/20 Piper Sandler
Capital One price target raised to $105 from $93 at Piper Sandler
10/26/20 BMO Capital
Capital One price target raised to $133 from $127 at BMO Capital
10/26/20 Deutsche Bank
Capital One price target raised to $83 from $73 at Deutsche Bank
COF Capital One
$87.77 /

-2.08 (-2.31%)

COF Capital One
$87.77 /

-2.08 (-2.31%)

COF Capital One
$87.77 /

-2.08 (-2.31%)

COF Capital One
$87.77 /

-2.08 (-2.31%)

Upgrade
State Street upgraded to Overweight from Underweight at Morgan Stanley » 05:16
11/30/20
11/30
05:16
11/30/20
05:16
STT

State Street

$71.67 /

-0.54 (-0.75%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STT State Street
$71.67 /

-0.54 (-0.75%)

STT State Street
$71.67 /

-0.54 (-0.75%)

11/18/20 Keefe Bruyette
State Street upgraded to Outperform from Market Perform at Keefe Bruyette
11/11/20 Deutsche Bank
State Street upgraded to Buy from Hold at Deutsche Bank
10/19/20 Deutsche Bank
State Street price target raised to $67 from $64 at Deutsche Bank
10/09/20 Citi
Citi opens '30-day positive Catalyst Watch' on State Street
STT State Street
$71.67 /

-0.54 (-0.75%)

STT State Street
$71.67 /

-0.54 (-0.75%)

STT State Street
$71.67 /

-0.54 (-0.75%)

Hot Stocks
Kingsoft Cloud to be added to MSCI China Index » 05:16
11/30/20
11/30
05:16
11/30/20
05:16
KC

Kingsoft Cloud

$42.00 /

+5.23 (+14.22%)

Kingsoft Cloud announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KC Kingsoft Cloud
$42.00 /

+5.23 (+14.22%)

KC Kingsoft Cloud
$42.00 /

+5.23 (+14.22%)

11/03/20 CLSA
Kingsoft Cloud initiated with a Buy at CLSA
06/29/20 Goldman Sachs
Kingsoft Cloud initiated with a Buy at Goldman Sachs
KC Kingsoft Cloud
$42.00 /

+5.23 (+14.22%)

  • 24
    Sep
  • 08
    May
KC Kingsoft Cloud
$42.00 /

+5.23 (+14.22%)

KC Kingsoft Cloud
$42.00 /

+5.23 (+14.22%)

Upgrade
Regions Financial upgraded to Overweight from Equal Weight at Morgan Stanley » 05:15
11/30/20
11/30
05:15
11/30/20
05:15
RF

Regions Financial

$15.63 /

-0.12 (-0.76%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RF Regions Financial
$15.63 /

-0.12 (-0.76%)

RF Regions Financial
$15.63 /

-0.12 (-0.76%)

11/06/20 Janney Montgomery Scott
Regions Financial downgraded to Neutral from Buy at Janney Montgomery Scott
10/30/20 UBS
Fifth Third downgraded to Neutral from Buy at UBS
10/06/20 JPMorgan
Regions Financial price target raised to $13.50 from $11.50 at JPMorgan
09/15/20 Odeon Capital
Regions Financial upgraded to Buy from Hold at Odeon Capital
RF Regions Financial
$15.63 /

-0.12 (-0.76%)

RF Regions Financial
$15.63 /

-0.12 (-0.76%)

RF Regions Financial
$15.63 /

-0.12 (-0.76%)

RF Regions Financial
$15.63 /

-0.12 (-0.76%)

Downgrade
Goldman Sachs downgraded to Underweight from Equal Weight at Morgan Stanley » 05:15
11/30/20
11/30
05:15
11/30/20
05:15
GS

Goldman Sachs

$235.35 /

-1.36 (-0.57%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

10/19/20 Credit Suisse
Goldman Sachs price target raised to $262 from $255 at Credit Suisse
10/15/20 BMO Capital
Goldman Sachs price target raised to $274 from $267 at BMO Capital
10/15/20 Oppenheimer
Goldman Sachs price target raised to $356 from $326 at Oppenheimer
10/15/20 Barclays
Goldman Sachs price target raised to $270 from $253 at Barclays
GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

GS Goldman Sachs
$235.35 /

-1.36 (-0.57%)

Downgrade
JPMorgan downgraded to Underweight from Overweight at Morgan Stanley » 05:15
11/30/20
11/30
05:15
11/30/20
05:15
JPM

JPMorgan

$121.33 /

-0.71 (-0.58%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

11/18/20 Keefe Bruyette
JPMorgan downgraded to Market Perform from Outperform at Keefe Bruyette
10/27/20 KeyBanc
Peloton promotion with Chase a positive subscriber catalyst, says KeyBanc
10/22/20 Mizuho
Square selloff on 'double whammy' a buying opportunity, says Mizuho
10/14/20 BMO Capital
JPMorgan price target raised to $119 from $117 at BMO Capital
JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

JPM JPMorgan
$121.33 /

-0.71 (-0.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.